Medtronic splashes up to $105m on Visualase; expands Lifetech deal
This article was originally published in Clinica
Executive Summary
It may have splurged nearly $43bn on Covidien, but Medtronic isn’t done spending yet: it has just completed the purchase of Visualase for $70m up front plus up to $35m in milestones. Houston, Texas-based Visualase has developed an FDA-approved MRI-guided laser and image guided system for minimally invasive neurosurgeries, including surgical thermal ablation.